Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06128720 · ClinicalTrials.gov registry record · NA
Hyperbaric Oxygen Therapy for Optic Neuropathies
A NA study of Glaucoma and Optic Neuropathy, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06128720 is a NA study of Glaucoma and Optic Neuropathy that is actively recruiting participants, run by Stanford University. The registered enrollment target is 60 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06128720, a NA study of Glaucoma and Optic Neuropathy, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
Conditions Studied
Interventions
- DEVICE Hyperbaric Oxygen
- DEVICE Sham Hyperbaric Oxygen
Study Locations (1)
California
- Byers Eye Institute - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06128720
The ClinicalTrials.gov registry entry for NCT06128720 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (93% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Hyperbaric Oxygen is the first listed.
NCT06128720 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06128720 about?
NCT06128720 is a clinical study titled "Hyperbaric Oxygen Therapy for Optic Neuropathies". The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
What is the current status of trial NCT06128720?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-11-01. Estimated completion is 2027-12.
What conditions does trial NCT06128720 study?
This clinical trial studies the following conditions: Glaucoma, Optic Neuropathy.
What interventions are being tested in trial NCT06128720?
The interventions under investigation include: Hyperbaric Oxygen (DEVICE), Sham Hyperbaric Oxygen (DEVICE).
Who is sponsoring clinical trial NCT06128720?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06128720 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.